Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Accured Expenses: 2018-2024

Historic Change in Accured Expenses for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $45.7 million.

  • Legend Biotech's Change in Accured Expenses rose 552.75% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.5 million, marking a year-over-year decrease of 116.72%. This contributed to the annual value of $45.7 million for FY2024, which is 3587.94% up from last year.
  • Per Legend Biotech's latest filing, its Change in Accured Expenses stood at $45.7 million for FY2024, which was up 3,587.94% from -$1.3 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Change in Accured Expenses ranged from a high of $140.7 million in FY2021 and a low of -$1.3 million during FY2023.
  • Moreover, its 3-year median value for Change in Accured Expenses was $45.7 million (2024), whereas its average is $54.6 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 101.10% in 2023, then soared by 3,587.94% in 2024.
  • Legend Biotech's Change in Accured Expenses (Yearly) stood at $26.9 million in 2020, then surged by 422.60% to $140.7 million in 2021, then fell by 15.25% to $119.3 million in 2022, then crashed by 101.10% to -$1.3 million in 2023, then spiked by 3,587.94% to $45.7 million in 2024.